Quick Answer
EyePoint, Inc. reported R&D Expense of $221.04 million for fiscal year 2025.
EyePoint, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $221.04M | +66.3% |
| 2024 | $132.93M | +105.6% |
| 2023 | $64.66M | +30.3% |
| 2022 | $49.64M | +74.2% |
| 2021 | $28.50M | +63.6% |
| 2020 | $17.42M | +13.4% |
| 2019 | $15.37M | -16.9% |
| 2018 | $18.50M | +14.4% |
| 2018 | $16.18M | +8.7% |
| 2017 | $14.88M | +3.5% |
| 2016 | $14.38M | +19.0% |
| 2015 | $12.09M | +26.3% |
| 2014 | $9.57M | +36.7% |
| 2013 | $7.00M | -0.5% |
| 2012 | $7.04M | +2.5% |
| 2011 | $6.86M | -1.9% |
| 2010 | $6.99M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $47.75M | +61.6% | -14.0% |
| June 30, 2025 | $55.50M | +86.1% | -5.3% |
| March 31, 2025 | $58.57M | +94.3% | +98.3% |
| September 30, 2024 | $29.54M | +70.1% | -0.9% |
| June 30, 2024 | $29.82M | +89.6% | -1.1% |
| March 31, 2024 | $30.14M | +121.3% | +73.6% |
| September 30, 2023 | $17.36M | +55.6% | +10.4% |
| June 30, 2023 | $15.73M | +21.1% | +15.5% |
- EyePoint, Inc. showed an increase of +66.3% in R&D Expense compared to the prior fiscal year.
- Over the 2010–2025 period, EyePoint, Inc.’s r&d expense has grown by 3060.4% (from $6.99 million to $221.04 million).
- The most recent figure is from EyePoint, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: